CIK 0001517022
- Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 208756903
- Phone
- +1 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- 4 Grant or award SVP, CLO & Secretary acquired 65,000 shares (grant or award)
- 4 Grant or award SVP, CFO & Treasurer acquired 65,000 shares (grant or award)
- 4 Grant or award CEO and President acquired 239,500 shares (grant or award)
- 4 Grant or award Director acquired 44,919 shares (grant or award)
- 4 Grant or award Director acquired 11,229 shares (grant or award)
- 4 Grant or award Director acquired 10,231 shares (grant or award)
- 4 Grant or award Director acquired 3,743 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 7,486 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes SVP, Chief Development Officer gave up 11,928 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Chief Medical Officer gave up 8,659 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, General Counsel, Sec. gave up 20,175 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Chief Business Officer gave up 23,385 shares (to pay taxes)
- 4 Shares withheld for taxes CEO & President gave up 135,697 shares (to pay taxes)
Page 11 of 19 · 378 filings